Application | Comment | Organism |
---|---|---|
medicine | treatment of 63 patients with metastatic adrenocortical carcinoma with oral nevanimibe at doses ranging from 1.6 mg/kg/day to 158.5 mg/kg/day. No patients experienced a complete or partial response. 13 of 48 (27%) patients who underwent imaging at 2 months had stable disease, and 4 of these had stable disease for more than 4 months | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
nevanimibe | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P35610 | - |
- |